Resumen
The staff within the Gene Transfer, Targeting and Therapeutics Viral Vector Core provide expert consultation for the safe and effective use of viral vector technologies, and offer custom design and production services for multiple viral vector types. The Gene Transfer, Targeting and Therapeutics Viral Vector Core facilitates the use of these powerful research tools by Salk researchers and others across diverse fields of study such as systems neuroscience, stem cell biology, metabolism, aging, cancer biology and gene therapy.
The U.S. Bureau of Industry and Security has updated the Export Administration Regulations regarding rabies vectors. We are now able to distribute reagents that contain any portion of the rabies genome only to countries that are part of the Australia Group:
https://www.dfat.gov.au/publications/minisite/theaustraliagroupnet/site/en/participants.html
Instituto Nacional del Cáncer
The GT3 core is a designated Cancer Center Council (C3) core facility. Cancer Center members from participating C3 institutes receive shared resource rates.
For submitting manuscripts that have made use of services or resources from this core, PLEASE ACKNOWLEDGE SUPPORT by inclusion of the following information:
“This work was supported by the GT3 Core Facility of the Salk Institute with funding from NIH-NCI CCSG: P30 CA014195”. Please acknowledge core staff where appropriate and consider authorship inclusion when scientific contributions merit.
Por favor, vincula cada publicación derivada del trabajo realizado en el núcleo a tu cuenta MyNCBI. Esto garantizará que las contribuciones de los NIH sean debidamente reconocidas en las solicitudes de renovación y continuación. Este requisito de los NIH debe cumplirse como parte de nuestros esfuerzos para proporcionar un acceso consistente a los recursos del núcleo financiados por stabling. Información sobre cómo vincular publicaciones se encuentra aquí»
10010 N Torrey Pines Rd
La Jolla, CA 92037
Teléfono: (858) 453-4100
Our offices are located just North of the Salk Institute in the Sanford Consortium for Regenerative Medicine building.
Office Location
Room 1318
Lab Location
Room 1106
GT3 Core email: GT3@salk.edu
John Naughton
Director, Gene Transfer, Targeting and Therapeutics Viral Vector Core
(858) 453-4100 ext. 1891
jnaughton@salk.edu
